 lesions on MRI after
stenting or endarterectomy for symptomatic carotid stenosis: a
substudy of the International Carotid Stenting Study (ICSS).
Lancet Neurol 2010;9:353-62.
44. Kwolek CJ, Jaff MR, Leal JI, Hopkins LN, Shah RM, Hanover TM, et al.
Results of the ROADSTER multicenter trial of transcarotid stenting
with dynamic ﬂow reversal. J Vasc Surg 2015;62:1227-34.
45. Malas MB, Leal Lorenzo JI, Nejim B, Hanover TM, Mehta M,
Kashyap V, et al. Analysis of the ROADSTER pivotal and extendedaccess cohorts shows excellent 1-year durability of transcarotid
stenting with dynamic ﬂow reversal. J Vasc Surg 2019;69:1786-96.
46. Kashyap VS, Schneider PA, Foteh M, Motaganahalli R, Shah R,
Eckstein HH, et al. Early outcomes in the ROADSTER 2 study of
transcarotid artery revascularization in patients with signiﬁcant carotid artery disease. Stroke 2020;51:2620-9.

20S

Journal of Vascular Surgery

AbuRahma et al

January Supplement 2022
47. Schermerhorn ML, Liang P, Eldrup-Jorgensen J, Cronenwett JL,
Nolan BW, Kashyap VS, et al. Association of transcarotid artery
revascularization vs transfemoral carotid artery stenting with stroke
or death among patients with carotid artery stenosis. JAMA
2019;322:2313-22.
48. Malas MB, Dakour-Aridi H, Kashyap VS, Eldrup-Jorgensen J,
Wang GJ, Motaganahalli RL, et al. Transcarotid revascularization
with dynamic ﬂow reversal versus carotid endarterectomy in the
Vascular Quality Initiative surveillance project [e-pub